Baxter International Inc. Share Price Wiener Boerse

Equities

BAX

US0718131099

Medical Equipment, Supplies & Distribution

Real-time Estimate Tradegate 11:04:31 29/05/2024 am IST 5-day change 1st Jan Change
31.2 EUR -0.72% Intraday chart for Baxter International Inc. -2.06% -10.46%

Financials

Sales 2024 * 15.11B 13.93B 1,258B Sales 2025 * 15.66B 14.44B 1,303B Capitalization 17.25B 15.9B 1,436B
Net income 2024 * 703M 648M 58.52B Net income 2025 * 950M 876M 79.08B EV / Sales 2024 * 1.78 x
Net Debt 2024 * 9.7B 8.95B 808B Net Debt 2025 * 8.8B 8.11B 733B EV / Sales 2025 * 1.66 x
P/E ratio 2024 *
18.4 x
P/E ratio 2025 *
15.1 x
Employees 60,000
Yield 2024 *
3.53%
Yield 2025 *
3.66%
Free-Float 74.27%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.72%
1 week-2.06%
Current month-17.38%
1 month-16.15%
3 months-17.72%
6 months-4.90%
Current year-10.46%
More quotes
1 week
31.18
Extreme 31.18
31.76
1 month
31.18
Extreme 31.18
38.04
Current year
31.18
Extreme 31.18
40.63
1 year
30.05
Extreme 30.05
44.35
3 years
30.05
Extreme 30.05
78.14
5 years
30.05
Extreme 30.05
86.78
10 years
30.05
Extreme 30.05
86.78
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 01/15/01
Director of Finance/CFO 54 18/23/18
Chief Tech/Sci/R&D Officer - 01/17/01
Members of the board TitleAgeSince
Director/Board Member 73 06/17/06
Director/Board Member 64 10/22/10
Director/Board Member 64 18/19/18
More insiders
Date Price Change
23/24/23 31.43 -1.58%
28/24/28 31.18 -0.91%
27/24/27 31.46 +0.29%
24/24/24 31.38 -0.17%
23/24/23 31.43 -1.58%

End-of-day quote Wiener Boerse, May 23, 2024

More quotes
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - medicines and medical devices (33.8%): products intended for treating hemophilia (substitution clotting factors) and immune deficiencies (multi-purpose immunoglobins), and used in intensive care (human albumin) and biosurgery (fibrin adhesive, surgical gel, bone substitutes, hemostatic compresses, etc.); - kidney dialysis drugs and equipment (30.1%); - systems for delivering medications and intravenous therapy (15.2%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, etc.; - other (20.1%). Export accounts for 52.7% of net sales.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
33.85 USD
Average target price
46.07 USD
Spread / Average Target
+36.09%
Consensus